Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.

Clin Drug Investig

Russian Cardiological Research and Production Complex, 3rd Cherepkovskaya st. 15A, Moscow, 121552, Russia.

Published: September 2017

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-017-0551-yDOI Listing

Publication Analysis

Top Keywords

erratum full-dose
4
full-dose perindopril/indapamide
4
perindopril/indapamide treatment
4
treatment difficult-to-control
4
difficult-to-control hypertension
4
hypertension fortissimo
4
fortissimo study
4
erratum
1
perindopril/indapamide
1
treatment
1

Similar Publications

Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.

Clin Drug Investig

September 2017

Russian Cardiological Research and Production Complex, 3rd Cherepkovskaya st. 15A, Moscow, 121552, Russia.

View Article and Find Full Text PDF

Corrections.

Crit Care Nurse

April 2016

In the December Ask the Experts article by Alexander and Zomp, “Best Practices: Full-Dose Delivery of Intravenous Medications via Infusion Pumps” (Crit Care Nurse. 2015;35(6):68–70), the authors would like to clarify that the Alaris pump referred to on page 70 is an older version and that the max rate is now the same for both primary and secondary settings on Alaris pumps (999 mL/h).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!